Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis

OBJECTIVE: To evaluate rates of serious organ specific immune-related adverse events, general adverse events related to immune activation, and adverse events consistent with musculoskeletal problems for anti-programmed cell death 1 (PD-1) drugs overall and compared with control treatments. DESIGN: S...

Descripción completa

Detalles Bibliográficos
Autores principales: Baxi, Shrujal, Yang, Annie, Gennarelli, Renee L, Khan, Niloufer, Wang, Ziwei, Boyce, Lindsay, Korenstein, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851471/
https://www.ncbi.nlm.nih.gov/pubmed/29540345
http://dx.doi.org/10.1136/bmj.k793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851471/
https://www.ncbi.nlm.nih.gov/pubmed/29540345
http://dx.doi.org/10.1136/bmj.k793

Ejemplares similares